Table 2.
The tumorigenesis-related pathways potentially regulated by ATB key active components
| No. | Term | Count | % | P Value | Genes |
|---|---|---|---|---|---|
| 1 | hsa04668: TNF signaling pathway | 6 | 46.15 | 6.02E-07 | MAPK1, CASP3, IL6, TNF, PTGS2, RELA |
| 2 | hsa04151: PI3K-Akt signaling pathway | 7 | 53.85 | 1.09E-05 | MAPK1, IL6, RELA, VEGFA, MTOR, CDK4, MYC |
| 3 | hsa04066: HIF-1 signaling pathway | 5 | 38.46 | 1.62E-05 | MAPK1, IL6, RELA, VEGFA, MTOR |
| 4 | hsa04010: MAPK signaling pathway | 5 | 38.46 | 7.00E-04 | MAPK1, CASP3, TNF, RELA, MYC |
| 5 | hsa04620: Toll-like receptor signaling pathway | 4 | 30.77 | 7.07E-04 | MAPK1, IL6, TNF, RELA |
| 6 | hsa04150: mTOR signaling pathway | 3 | 23.08 | 4.37E-03 | MAPK1, TNF, MTOR |
| 7 | hsa04370: VEGF signaling pathway | 3 | 23.08 | 4.82E-03 | MAPK1, PTGS2, VEGFA |
| 8 | hsa04210: Apoptosis | 3 | 23.08 | 4.98E-03 | CASP3, TNF, RELA |
| 9 | hsa04350: TGF-beta signaling pathway | 3 | 23.08 | 8.98E-03 | MAPK1, TNF, MYC |
| 10 | hsa04012: ErbB signaling pathway | 3 | 23.08 | 9.61E-03 | MAPK1, MTOR, MYC |
| 11 | hsa04064: NF-kappa B signaling pathway | 3 | 23.08 | 9.61E-03 | TNF, PTGS2, RELA |